Carlson Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-772,800
Closed -$23.7M 299
2017
Q1
$23.7M Buy
+772,800
New +$21.8M 0.3% 107
2016
Q1
Sell
-50,000
Closed -$1.5M 356
2015
Q4
$1.5M Buy
+50,000
New +$1.7M 0.02% 276

Other funds holding DBD

Carlson Capital's DBD Position: Q2 2017 in Review

Carlson Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2017, closing a stake of 772,800 shares — an estimated $23.7M sold.

Carlson Capital first reported a position in DBD in Q4 2015 and held it in 2 quarters. The position peaked at $23.7M in Q1 2017. 235 funds tracked by Wall St. Rank hold DBD as of Q2 2017.

  • Carlson Capital reported no remaining Diebold Nixdorf Incorporated position as of Q2 2017 after selling out during the quarter.
  • Carlson Capital sold 772,800 Diebold Nixdorf Incorporated shares in Q2 2017, an estimated $23.7M.
  • Carlson Capital first reported a position in Diebold Nixdorf Incorporated in Q4 2015 and held it in 2 quarters.
  • Carlson Capital's Diebold Nixdorf Incorporated position peaked at $23.7M in Q1 2017.
  • 235 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2017.

Based on Carlson Capital's 13F filing for Q2 2017, filed 14 Aug 2017.